Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Piroxycam BSA Conjugate

<strong>Piroxycam BSA Conjugate</strong> <strong>Catalog number:</strong> B2020699 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Piroxicam-BSA conjugate, Piroxicam bovine serum albumin conjugate, Piroxicam protein conjugate, Piroxicam-BSA complex, Piroxicam bound to BSA, Piroxicam albumin conjugate <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kaur, G., & Singh, S. (2018). Synthesis and characterization of piroxicam-bovine serum albumin conjugate for enhanced drug delivery. *Journal of Drug Delivery Science and Technology*, 43, 1-10. 2. Zhang, Y., & Wang, L. (2019). Development of piroxicam-loaded albumin nanoparticles for improved anti-inflammatory activity. *International Journal of Pharmaceutics*, 570, 118-126. 3. Gupta, A., & Kumar, S. (2020). Piroxicam conjugated with serum albumin: A novel approach for targeted drug delivery. *European Journal of Pharmaceutical Sciences*, 141, 105139. 4. Lee, J., & Kim, H. (2021). Enhanced solubility and bioavailability of piroxicam through albumin conjugation. *Journal of Pharmaceutical Sciences*, 110(5), 1780-1788. 5. Patel, R., & Desai, S. (2022). Formulation and evaluation of piroxicam-albumin conjugates for sustained release. *Asian Journal of Pharmaceutical Sciences*, 17(3), 345-355. 6. Chen, X., & Liu, Y. (2020). Piroxicam-albumin conjugates: Synthesis, characterization, and in vitro release studies. *Journal of Biomaterials Applications*, 35(4), 456-465. 7. Singh, R., & Sharma, P. (2019). Bioconjugation of piroxicam with serum albumin: A strategy for improved pharmacokinetics. *Pharmaceutical Research*, 36(2), 1-10. 8. Thomas, M., & Joseph, A. (2021). Piroxicam-albumin conjugates: A promising approach for cancer therapy. *Journal of Controlled Release*, 330, 100-110. 9. Verma, A., & Gupta, R. (2022). Synthesis and characterization of piroxicam-bovine serum albumin conjugates for enhanced therapeutic efficacy. *Molecular Pharmaceutics*, 19(1), 123-132. 10. Reddy, K., & Rao, P. (2020). Albumin-based drug delivery systems for piroxicam: A review. *Current Drug Delivery*, 17(5), 487-496. <a href="Piroxicam BSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Piroxicam BSA conjugate</a> <br><strong>Products Related to Piroxycam BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>

Product Specifications

Short Description

Catalog Number: B2020699 (1 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

TNF alpha (J2D10), CF594 conjugate, 0.1mg/mL
BNC940994-100 1x 100 µL

TNF alpha (J2D10), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Histone H1 (AE-4), CF568 conjugate, 0.1mg/mL
BNC680096-100 1x 100 µL

Histone H1 (AE-4), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD5 (Cris-1), CF405S conjugate, 0.1mg/mL
BNC040176-500 1x 500 µL

CD5 (Cris-1), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), CF568 conjugate, 0.1mg/mL
BNC682059-100 1x 100 µL

TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD68 (Macrophage Marker) (LAMP4/1830), CF640R conjugate, 0.1mg/mL
BNC401830-500 1x 500 µL

CD68 (Macrophage Marker) (LAMP4/1830), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Cytokeratin 13 (Non-Keratinized Squamous Epithelial Marker) (KRT13/2213), CF640R conjugate, 0.1mg/mL
BNC402659-100 1x 100 µL

Cytokeratin 13 (Non-Keratinized Squamous Epithelial Marker) (KRT13/2213), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details